A local pre-approval access program to determine tolerability and effectiveness of atezolizumab combined with chemotherapy in extensive stage small cell lung cancer patients in real world setting
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology